Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Oct 1;181(7):4752-60.
doi: 10.4049/jimmunol.181.7.4752.

Transplantation survival is maintained by granzyme B+ regulatory cells and adaptive regulatory T cells

Affiliations

Transplantation survival is maintained by granzyme B+ regulatory cells and adaptive regulatory T cells

David C Gondek et al. J Immunol. .

Abstract

Granzyme B (GZB) has been implicated as an effector mechanism in regulatory T cells (T(reg)) suppression. In a model of T(reg)-dependent graft tolerance, it is shown that GZB- deficient mice are unable to establish long-term tolerance. Moreover, mice overexpressing the inhibitor of GZB, serine protease inhibitor 6, are also resistant to tolerization to alloantigen. Graft survival was shorter in bone marrow-mixed chimeras reconstituted with GZB-deficient T(reg) as compared with wild-type T(reg). Whereas there was no difference in graft survival in mixed chimeras reconstituted with wild-type, perforin-deficient, or Fas ligand-deficient T(reg). Finally, data also show that if alloreactive effectors cannot express FoxP3 and be induced to convert in the presence of competent T(reg), then graft tolerance is lost. Our data are the first in vivo data to implicate GZB expression by T(reg) in sustaining long-lived graft survival.

PubMed Disclaimer

Conflict of interest statement

Disclosures: The authors have no financial conflict of interest.

Figures

FIGURE 1
FIGURE 1
Spi-6Tg T cells are resistant to Treg-mediated suppression via GZB. CD4+CD25+ (Treg) and CD4+CD25 (Teff) cells were isolated from mice via Miltenyi Biotec magnetic selection. All populations were >90% pure. Teff cells were labeled with CFSE and cocultured with Treg at ratios described. GZB-resistant Spi-6Tg Teff were resilient to suppression (A). However, Wt Teff were fully suppressed by Wt and PRF−/− Treg (A and B). PRF−/− Teff also manifested a resistance to Wt Treg- mediated suppression (B). Data are the average of three independent experiments. Tritium incorporation demonstrates similar trends (data not shown). Groups were normalized to Teff alone proliferation (*, p < 0.05; **, p < 0.001; and ***, p < 0.005).
FIGURE 2
FIGURE 2
GZB−/− and Spi-6Tg mice are defective in maintaining long-term graft survival via DST/anti-CD154 costimulatory blockade. C57BL/6 mice were given i.v. injections of 3 × 107 T-depleted splenocytes (DST) from CB6F1 mice in conjunction with i.p. injections of 250 μg of anti-CD154 on days −7, −5, and −3 (A). On day 0, mice were grafted with CB6F1 tail skin. Nontolerized mice, deficient in GZB, had no delay in their ability to reject skin grafts compared with Wt mice (p = 0.7; B). However, mice deficient in GZB were unable to maintain allografts to the same extent as their Wt counterparts (p = 0.016; B). PRF−/− mice also manifested a deficiency in maintenance of allografts (p < 0.05), as has been previously reported (43) (B). Mice overexpressing Spi-6, a GZB-specific inhibitor, manifested decreased graft survival as compared with tolerized Wt mice (p < 0.01). This loss of graft survival in Spi-6Tg mouse is similar to that of the GZB−/− mouse (B and C).
FIGURE 3
FIGURE 3
Clonal exhaustion of Ag-specific T cells is a GZB, PRF-independent event. Mice were tolerized to DST via anti-CD154 blockade and coadoptively transferred with 1 × 106 CD45.1+ TEa Tg T cells. Five days after transfer, spleen and LN were analyzed for expression of CD44, CD62L, and up-regulation of IFN-γ. Loss of either GZB or PRF expression in the host had no impact on the tolerizing capacity of DST/anti-CD154. Data are representative of four independent experiments.
FIGURE 4
FIGURE 4
Treg in tolerant skin express GZB. Sixty days postsurgery, graft tissue was excised and sectioned for histological analysis. For comparison, 7-day-old grafts from nontolerized mice were also examined. Tolerant as well as rejecting grafts showed high levels of cellular infiltration compared with syngenic skin (A). Rejecting grafts were predominantly infiltrated with CD4GZB+ cells, whereas tolerant grafts were infiltrated with CD4+ cells (A–D). A large proportion of CD4+ cells in tolerant grafts were also expressing FoxP3 and a proportion of those FoxP3+ cells coexpressed GZB (arrows, A). Enumeration of the histology showed tolerant grafts contained 3-fold more CD4+ cells than syngeneic grafts (B). This CD4+ cell infiltration was mediated principally by CD4+FoxP3+ cells, as a 13 times increase in Treg infiltration was seen, compared with syngeneic grafts (p < 0.005; B). Additionally, of these FoxP3+ cells, a 2-fold increase in GZB+ cells was observed in situ (p < 0.05; D). *, p < 0.05 and ***, p < 0.005).
FIGURE 5
FIGURE 5
GZB must be expressed in Treg to mediate long-term graft survival. To eliminate cytolytic function within FoxP3+ Treg, we preformed mixed BM chimeras. Mice were lethally irradiated via a split dose of 1200 rad, then hematopoietically repopulated by a 3:1 transfer of Sf and Wt or knockout BM (A). After 8–10 wk of reconstitution, CD4+ cells (bottom right) maintained the same ratio of chimerism as was identified in the entire host (top left), whereas the CD4+FoxP3+ cells (top right) derived almost entirely from the non-Sf BM (B); some Treg emanated from the residual host BM. Following tolerization by DST/anti-CD154 blockade, mice were grafted and maintenance of the grafts was monitored. Tolerized mice reconstituted with Sf and Wt mix were able to established extended tolerance compared with control nontolerized mice (p < 0.0001; C). However, if mice were reconstituted with Sf and GZB−/− BM, long-term graft survival could not be maintained (p < 0.0001). This loss of tolerization was due to a defect in the Treg compartment since reconstitution of mice with Wt and GZB−/− BM did not show this defect in survival, instead showing improved survival compared with Sf and Wt controls (p < 0.001). This loss of graft survival is not due to a perforin-dependent defect in the Treg themselves, as mice reconstituted with Sf and PRF−/− BM showed no loss of suppression (p = 0.59; D). To restrict the loss of FasL function to FoxP3+ Treg, we performed similar mixed BM chimeras. Mice reconstituted with Sf and GLD−/− BM maintained grafts in duration comparable to that of controls (p = 0.27; E). Rag −/− mice reconstituted with 99% pure FACS-purified Teff or Treg also demonstrated that a loss of Treg GZB expression was detrimental to graft survival. TEa+ CD4-reconstituted Rag−/− had a significantly accelerated graft decay compared with their Wt Treg controls (p < 0.005; F). Whereas 2C+ CD8-reconstituted Rag mice showed earlier rejection kinetics, but no statistical difference in graft decay compared with Wt Treg controls (p = 0.7; G).
FIGURE 6
FIGURE 6
Induction of FoxP3 determines regulator/effector status. To determine the effector population mediating rejection, Sf and Wt chimera CD4+ and CD8+ cells were isolated from mice 20-30 days after graft rejection. Cells were further separated based on the CD45.1/2 expression by flow sorting. Purified T cells were then recalled by CD40-activated B cell blasts from C57BL/6 or CB6F1 mice and examined via ELISPOT for IFN-γ production. The CD4+ Sf-deficient derived cells in the mixed chimeras were the main component of the allospecific recall response (p < 0.0001). Moreover, the CD8 compartment also showed a skew toward the Sf compartment in allospecific memory (p < 0.005).

Similar articles

Cited by

References

    1. Billingham B, Brent L, Medawar P. Actively acquired tolerance of foreign cells. Nature. 1953;172:603–606. - PubMed
    1. Burnet F. Self and Not-Self. Cambridge Univ. Press; Cambridge, MA: 1969.
    1. Quezada SA, Jarvinen LZ, Lind EF, Noelle RJ. CD40/CD154 interactions at the interface of tolerance and immunity. Annu Rev Immunol. 2004;22:307–328. - PubMed
    1. Jones ND, Van Maurik A, Hara M, Spriewald BM, Witzke O, Morris PJ, Wood KJ. CD40-CD40 ligand-independent activation of CD8+ T cells can trigger allograft rejection. J Immunol. 2000;165:1111–1118. - PubMed
    1. Jarvinen LZ, Blazar BR, Adeyi OA, Strom TB, Noelle RJ. CD154 on the surface of CD4+CD25+ regulatory T cells contributes to skin transplant tolerance. Transplantation. 2003;76:1375–1379. - PubMed

MeSH terms